,trastuzumab deruxtecan
daiichi sankyo,astrazeneca
[]
managed to avoid the #asco22 press briefing, nejm paper, and spoiler write-ups in my inbox this am because i wanted to enjoy the db04 presentation/discussion fresh... so worth it!
Scientist, cancer geek, journalist, Londoner ??????????????, adventurer, explorer, immigrant, lover of curry, fine wine, football, & spy novels.